Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

IDT Opens SGD 6 Million Manufacturing Facility in Singapore

Published: Wednesday, July 24, 2013
Last Updated: Wednesday, July 24, 2013
Bookmark and Share
IDT is now able to provide locally-manufactured oligonucleotides to researchers in Singapore and throughout the region.

In January of 2012, IDT acquired the oligo business of Singapore’s top supplier, 1st BASE Pte. Ltd. Shortly thereafter, IDT began work to create a state-of-the art hub for oligo manufacturing and support dedicated to the Asian market. IDT completed the nearly SGD 6 million project in spring of 2013, and the Singapore company’s synthesis and other processes are now fully integrated with IDT’s operations in the US and Europe.

IDT’s investment in Singapore means that researchers throughout the region can now enjoy quicker delivery of the same high quality custom nucleic acid products they expect from IDT. Through its Asian network of highly skilled sales professionals and 21 appointed distributors, IDT now serves Malaysia, Indonesia, Thailand, Taiwan, the Philippines, Vietnam, Bangladesh, Hong Kong, Nepal, Sri Lanka, and Myanmar from its Singapore company. In the coming months, IDT will expand the services it offers from Singapore to include all the Asia Pacific region’s major markets.

“Our new synthesis and support capabilities in Singapore increase the speed with which we can deliver IDT products to our customers in Asia by 2-3 days,” noted Trey Martin, Chief Operating Officer at IDT. “Scientists can move forward with their research that much more quickly, which will add to the value IDT already contributes to their important work.”

Said Dr Joseph A. Walder, Founder and CEO of IDT, “For several years, we’ve looked forward to the day that we could bring to Asia what has made IDT so successful in North America and Europe – the highest quality custom biology products, delivered quickly, at prices that enable new and more research.  Our team in Asia now has a world class facility in Singapore, with the support of IDT’s global infrastructure backing it up.  We’re proud today to offer its benefits to the scientific community in Asia.”

“We strongly welcome IDT’s decision to set up a new oligonucleotide manufacturing facility that supports the scientific community in Singapore and the extended Asia Pacific region. Oligonucleotide manufacturing is knowledge-intensive, and requires a high proportion of skilled degree and diploma holders. This new investment will create excellent job opportunities for Singaporeans,” said Mr Kevin Lai, Director, Biomedical Sciences, Singapore Economic Development Board.

To celebrate, IDT will host an opening ceremony on Wednesday, 24 July from 4 pm to 6 pm. The event will include facility tours, networking, and presentations by IDT’s leadership. The presentations will highlight IDT’s latest innovations in support of synthetic biology, next generation sequencing, and quantitative PCR applications.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.
13 Ways to Stop an Unseen Force from Disrupting Weighing
Download a free Mettler Toledo paper to discover how to halt static’s negative effects before the next weigh-in.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos